These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11384686)

  • 1. A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1.
    Nyambi PN; Burda S; Bastiani L; Williams C
    J Immunol Methods; 2001 Jul; 253(1-2):253-62. PubMed ID: 11384686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.
    Nyambi PN; Mbah HA; Burda S; Williams C; Gorny MK; Nádas A; Zolla-Pazner S
    J Virol; 2000 Aug; 74(15):7096-107. PubMed ID: 10888650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.
    Nyambi PN; Gorny MK; Bastiani L; van der Groen G; Williams C; Zolla-Pazner S
    J Virol; 1998 Nov; 72(11):9384-91. PubMed ID: 9765494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
    Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
    J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.
    Gorny MK; Williams C; Volsky B; Revesz K; Cohen S; Polonis VR; Honnen WJ; Kayman SC; Krachmarov C; Pinter A; Zolla-Pazner S
    J Virol; 2002 Sep; 76(18):9035-45. PubMed ID: 12186887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining human immunodeficiency virus (HIV) type 1 immunotypes with six human monoclonal antibodies.
    Nádas A; Zhong P; Burda S; Zekeng L; Urbanski M; Gorny MK; Zolla-Pazner S; Nyambi PN
    AIDS Res Hum Retroviruses; 2004 Jan; 20(1):55-65. PubMed ID: 15000699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.
    Gorny MK; Revesz K; Williams C; Volsky B; Louder MK; Anyangwe CA; Krachmarov C; Kayman SC; Pinter A; Nadas A; Nyambi PN; Mascola JR; Zolla-Pazner S
    J Virol; 2004 Mar; 78(5):2394-404. PubMed ID: 14963135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
    Moore JP; Sattentau QJ; Wyatt R; Sodroski J
    J Virol; 1994 Jan; 68(1):469-84. PubMed ID: 7504741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic properties of the HIV envelope on virions in solution.
    Ray K; Mengistu M; Yu L; Lewis GK; Lakowicz JR; DeVico AL
    J Virol; 2014 Feb; 88(3):1795-808. PubMed ID: 24284318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.
    Nyambi PN; Nádas A; Mbah HA; Burda S; Williams C; Gorny MK; Zolla-Pazner S
    J Virol; 2000 Nov; 74(22):10670-80. PubMed ID: 11044111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120.
    Jeffs SA; Gorny MK; Williams C; Revesz K; Volsky B; Burda S; Wang XH; Bandres J; Zolla-Pazner S; Holmes H
    Immunol Lett; 2001 Dec; 79(3):209-13. PubMed ID: 11600200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies.
    Laal S; Burda S; Gorny MK; Karwowska S; Buchbinder A; Zolla-Pazner S
    J Virol; 1994 Jun; 68(6):4001-8. PubMed ID: 7514683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.
    Moore JP; McCutchan FE; Poon SW; Mascola J; Liu J; Cao Y; Ho DD
    J Virol; 1994 Dec; 68(12):8350-64. PubMed ID: 7525988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
    Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
    Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
    Mitchell WM; Ding L; Gabriel J
    AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner.
    Musich T; Li L; Liu L; Zolla-Pazner S; Robert-Guroff M; Gorny MK
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades.
    Mbah HA; Burda S; Gorny MK; Williams C; Revesz K; Zolla-Pazner S; Nyambi PN
    J Virol; 2001 Aug; 75(16):7785-8. PubMed ID: 11462056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
    Boots LJ; McKenna PM; Arnold BA; Keller PM; Gorny MK; Zolla-Pazner S; Robinson JE; Conley AJ
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1549-59. PubMed ID: 9430247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.